Has SLT study shed new light on treating eye conditions? (C-100422)

CPD
1
31 July 2019
Summer 2019

Graham Clews reports on the potential impact of SLT, as a study finds it could reduce the need for traditional treatments for glaucoma or ocular hypertension.

Domains covered

Communication Clinical practice

Drops first, laser treatment second, and surgery third. That’s been the traditional treatment pathway for glaucoma or ocular hypertension.

Around eight million prescriptions for medications, generally eye drops, are written in the UK each year for this condition and are often effective (Connor and Fraser, 2014). Around a third of UK patients need more than one type of drop (Moorfields, 2015) and long-term use is associated with significant side effects (Waterman et al, 2013). 

Irritation, red eyes, iris colour changes, and hyperpigmentation of eyelid skin can all lead patients to leave drops unused, and non-compliance rates can be as high as 50% (NICE, 2017a).

Sign in to continue

Forgotten password?
Register

Not already a member of The College?

Start enjoying the benefits of College membership today. Take a look at what the College can offer you and view our membership categories and rates.

Related further reading

This online therapeutics peer review session is open to College members who are qualified independent prescribers or studying for an IP qualification.

This interactive online session will explore ways eye care professionals can adapt a patient centred approach to contact lens recommendation and management.

This interactive online session will explore ways eye care professionals can adapt a patient centred approach to contact lens recommendation and management.